Teva Pharma (TEVA) Announces New Clinical and Real-World Data Evaluating Efficacy of AJOVY (fremanezumab-vfrm) Injection and Reduction of Migraine Burden

Go back to Teva Pharma (TEVA) Announces New Clinical and Real-World Data Evaluating Efficacy of AJOVY (fremanezumab-vfrm) Injection and Reduction of Migraine Burden

Johnson & Johnson (JNJ) California Opiod Trial to Take Center Stage this Week

April 19, 2021 7:38 AM EDT

RBC analyst, Daniel Busby, noted that The Orange County, CA opioid trial is scheduled to begin on Monday, 4/19 with Johnson & Johnson (NYSE: JNJ), Teva Pharma (NYSE: TEVA), Endo International (NASDAQ: ENDP), and AbbVie... More